Skip Nav Destination
Issues
1 March 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Editorial
The Biology Behind
Human Cancer Biology
Heregulin-Induced Activation of HER2 and HER3 Increases Androgen Receptor Transactivation and CWR-R1 Human Recurrent Prostate Cancer Cell Growth
Christopher W. Gregory; Young E. Whang; Wesley McCall; Xiaoyin Fei; Yuanbo Liu; Liliana A. Ponguta; Frank S. French; Elizabeth M. Wilson; H. Shelton Earp, III
Influence of CD80, Interleukin-2, and Interleukin-7 Expression in Human Renal Cell Carcinoma on the Expansion, Function, and Survival of Tumor-Specific CTLs
Bernhard Frankenberger; Heike Pohla; Elfriede Noessner; Gerald Willimsky; Britta Papier; Antonio Pezzutto; Joachim Kopp; Ralph Oberneder; Thomas Blankenstein; Dolores J. Schendel
Imaging, Diagnosis, Prognosis
Elevated Serum Cytokines Correlated with Altered Behavior, Serum Cortisol Rhythm, and Dampened 24-Hour Rest-Activity Patterns in Patients with Metastatic Colorectal Cancer
Tyvin Rich; Pasquale F. Innominato; Julie Boerner; M. Christine Mormont; Stefano Iacobelli; Benoit Baron; Claude Jasmin; Francis Lévi
Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non–Small Cell Lung Carcinomas
Shin-ichi Fukumoto; Naoko Yamauchi; Hisashi Moriguchi; Yoshitaka Hippo; Akira Watanabe; Junji Shibahara; Hirokazu Taniguchi; Shumpei Ishikawa; Hirotaka Ito; Shogo Yamamoto; Hiroko Iwanari; Mitsugu Hironaka; Yuichi Ishikawa; Toshiro Niki; Yasunori Sohara; Tatsuhiko Kodama; Masaharu Nishimura; Masashi Fukayama; Hirotoshi Dosaka-Akita; Hiroyuki Aburatani
Prognostic Validation of the International Classification of Immunoglobulin M Gammopathies: A Survival Advantage for Patients with Immunoglobulin M Monoclonal Gammopathy of Undetermined Significance?
Paolo G. Gobbi; Luca Baldini; Chiara Broglia; Maria Goldaniga; Mario Comelli; Pierre Morel; Enrica Morra; Sergio Cortelazzo; Roberto Bettini; Giampaolo Merlini
Fractional Genomic Alteration Detected by Array-Based Comparative Genomic Hybridization Independently Predicts Survival after Hepatic Resection for Metastatic Colorectal Cancer
Kshama R. Mehta; Kentaro Nakao; Marlene B. Zuraek; Daniel T. Ruan; Emily K. Bergsland; Alan P. Venook; Dan H. Moore; Taku A. Tokuyasu; Ajay N. Jain; Robert S. Warren; Jonathan P. Terdiman; Frederic M. Waldman
Cancer Therapy: Clinical
Phase I Clinical and Pharmacokinetic Study of Kahalalide F in Patients with Advanced Androgen Refractory Prostate Cancer
Jeany M. Rademaker-Lakhai; Simon Horenblas; Willem Meinhardt; Ellen Stokvis; Theo M. de Reijke; José M. Jimeno; Luis Lopez-Lazaro; José A. Lopez Martin; Jos H. Beijnen; Jan H.M. Schellens
A Phase I Trial of the Novel Farnesyl Protein Transferase Inhibitor, BMS-214662, in Combination with Paclitaxel and Carboplatin in Patients with Advanced Cancer
Grace K. Dy; Laura M. Bruzek; Gary A. Croghan; Sumithra Mandrekar; Charles Erlichman; Prema Peethambaram; Henry C. Pitot; Lorelei J. Hanson; Joel M. Reid; Alfred Furth; Shinta Cheng; Robert E. Martell; Scott H. Kaufmann; Alex A. Adjei
A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy
Ian D. Davis; Lynette Kiers; Lachlan MacGregor; Michael Quinn; Joseph Arezzo; Michael Green; Mark Rosenthal; Michael Chia; Michael Michael; Peter Bartley; Leonie Harrison; Michael Daly
Intratumoral Recombinant Human Interleukin-12 Administration in Head and Neck Squamous Cell Carcinoma Patients Modifies Locoregional Lymph Node Architecture and Induces Natural Killer Cell Infiltration in the Primary Tumor
Carla M.L. van Herpen; Jeroen A.W.M. van der Laak; I. Jolanda M. de Vries; Johan H. van Krieken; Peter C. de Wilde; Michiel G.J. Balvers; Gosse J. Adema; Pieter H.M. De Mulder
A Phase I Study of α-Galactosylceramide (KRN7000)–Pulsed Dendritic Cells in Patients with Advanced and Recurrent Non–Small Cell Lung Cancer
Aki Ishikawa; Shinichiro Motohashi; Eiichi Ishikawa; Hiroki Fuchida; Kazuko Higashino; Mizuto Otsuji; Toshihiko Iizasa; Toshinori Nakayama; Masaru Taniguchi; Takehiko Fujisawa
Cancer Therapy: Preclinical
Cure of Mammary Carcinomas in Her-2 Transgenic Mice through Sequential Stimulation of Innate (Neoadjuvant Interleukin-12) and Adaptive (DNA Vaccine Electroporation) Immunity
Michela Spadaro; Elena Ambrosino; Manuela Iezzi; Emma Di Carlo; Pamela Sacchetti; Claudia Curcio; Augusto Amici; Wei-Zen Wei; Piero Musiani; Pier-Luigi Lollini; Federica Cavallo; Guido Forni
Farnesyltransferase Inhibitors and Human Malignant Pleural Mesothelioma: A First-Step Comparative Translational Study
Alfredo Cesario; Alessia Catassi; Luigi Festi; Andrea Imperatori; Andrea Pericelli; Domenico Galetta; Stefano Margaritora; Venanzio Porziella; Vittorio Cardaci; Pierluigi Granone; Lorenzo Dominioni; Patrizia Russo
Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871
Bruce D. Cohen; Deborah A. Baker; Catherine Soderstrom; George Tkalcevic; Ann Marie Rossi; Penny E. Miller; Mark W. Tengowski; Faye Wang; Antonio Gualberto; Jean S. Beebe; James D. Moyer
Cancer Prevention
Effect of the Synthetic Retinoid Fenretinide on Circulating Free Prostate-Specific Antigen, Insulin-Like Growth Factor-I, and Insulin-Like Growth Factor Binding Protein-3 Levels in Men with Superficial Bladder Cancer
Davide Serrano; Laura Baglietto; Harriet Johansson; Frederique Mariette; Rosalba Torrisi; Marina Onetto; Michela Paganuzzi; Andrea Decensi
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.